Vasoprotective effects of nitric oxide in atherosclerosis

Fabad Journal of Pharmaceutical Sciences

Volumn 30, Issue 1, 2005, Pages 41-53

  Yasa, Mukadder ^a   Türkseven, Saadet ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Endothelial dysfunction; Endothelium; Nitric oxide

Indexed keywords

EID: 77952921863     PISSN: 13004182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, 373-376, 1980. (Pubitemid 11169009)
2. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, 524-526, 1987. (Pubitemid 17085822)
3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yasaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, 332, 411-415, 1988. (Pubitemid 18090241)
4. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor, Am J Physiol, 257, H33-H37, 1989.
5. Quyyumi AA. Circadian variation in myocardial ischemia: pathophysiologic mechanism. In: Stern S (ed), Silent Myocardial Ischemia, Martin Dunitz, Ltd., London, 159-174, 1998.
6. Luscher TF, Barton M. Biology of the endothelium, Clin Cardiol, 20 (Suppl. II), II-3-II-10, 1997.
7. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease, Curr Opin Lipidol, 12, 383-389, 2001. (Pubitemid 32675498)
8. Cooke JP. The pivotal role of nitric oxide for vascular health, Can J. Cardiol, 20 (Suppl B), 7B-15B, 2004.
9. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide, Proc. Natl. Acad. Sci. USA, 84, 9265-9269, 1987.
10. Lin S, Fagan KA, Li KX, Shaul PW, Cooper DM, Rodman DM. Sustained endothelial nitric oxide synthase activation requires capacitative Ca2+ entry, J. Biol Chem, 275, 17979-17985, 2000. (Pubitemid 30414743)
11. Bucci M, Gratton JP, Rudic RD. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation, Nature Med, 6, 1362-1367, 2000. (Pubitemid 32001020)
12. Forstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath L. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning and functions, Hypertension, 23, 1121-1131, 1994. (Pubitemid 24180877)
13. Barbato JE, Tzeng E. Nitric oxide and arterial disease, J Vasc Surg, 40, 187-193, 2004.
14. Tuteja N, Chandra M, Tuteja R, Misra MK. Nitric oxide as a unique bioactive signaling messenger in physiology and pathophysiology, J. Biomed Biotech, 4, 227-237, 2004. (Pubitemid 40128959)
15. Miljkovic D, Trajkovic V. Inducible nitric oxide synthase activation by interleukin-17, Cytokine Growth Factor Rev, 15, 21-32, 2004. (Pubitemid 38121288)
16. Gewalting MT, Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential, Cardiovasc Res, 55, 250-260, 2002. (Pubitemid 34775275)
17. Ruiz-Stewart I, Tiyyagura SR, Lin J, Kazeorunian S, Pitari GM, Schultz S, Martin E, Murad F, Waldman SA. Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism, Proc. Natl. Acad Sci. USA, 101, 37-42, 2004. (Pubitemid 38084199)
18. Kanagy NL, Charpie JR, Webb RC. Nitric oxide regulation of ADP-ribosylation of G proteins in hypertension, Med Hypotheses, 44, 159-163, 1995.
19. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP, Circulation, 92, 3337-3349, 1995.
20. Gardiner SM, Compton AM, Bennett T, Palmer RM, Moncada S. Control of regional blood flow of endothelium-derived nitric oxide, Hypertension, 15, 486-492, 1990. (Pubitemid 20148039)
21. Tronc F, Wassef M, Esposito B, Henrion D, Glagov S, Tedgui A. Role of NO in flow-induced remodeling of the rabbit common carotid artery, Arterioscler Thromb Vasc Biol, 6, 1256-1262, 1996. (Pubitemid 26339713)
22. Garg UC, Hassid A. Nitric oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells, J. Clin Invest, 83, 1774-1777, 1989. (Pubitemid 19124139)
23. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries, N. Engl. J. Med, 315, 1046-1051, 1986.
24. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J. Am. Coll. Cardiol, 30, 325-333, 1997.
25. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia, Circulation, 91, 2345-2352, 1995.
26. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR, Quyyumi AA. Prognostic value of coronary vascular endothelial function, Circulation, 106, 653-658, 2002. (Pubitemid 34851922)
27. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease, Arterioscler Thromb. Vasc. Biol, 25, 29-38, 2005.
28. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production, J. Clin. Invest, 91, 2546-2551, 1993. (Pubitemid 23182507)
29. Guzik TJ, West NE, Black E, McDonalds E, Ramatunga C, Pillai R, Channon KM. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors, Clin Res, 86, E85-E90, 2000.
30. Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creager MA. L-arginine augments endotheliumdependent vasodilation in cholesterol-fed rabbits, Circ Res, 67, 1301-1308, 1990.
31. Boger RH, Bode-Boger SM, Thiele W, Creutzig A, Alexander K, Frolich JC. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease, J. Am. Coll. Cardiol., 32, 1336-1344, 1998.
32. Kauser K, da Cunha V, Fitch R, Mallari C, Rubanyi GM. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice, Am. J. Physiol., 278, H1679-H1685, 2000.
33. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, Marsden PA. Expression of multiple isoforms of nitric oxide sythase in normal and atherosclerotic vessels, Arterioscler Thromb Vasc Biol, 17, 2479-2488, 1997.
34. Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Luscher TF. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis, Circulation, 97, 2494-2498, 1998.
35. Mozes G, Kullo IJ, Mohacsi TG, Cable DG, Spector DJ, Croty TB, Gloviczki P, Katusic ZS, O'Brien T. Ex vivo gene transfer of endothelial nitric oxide synthase to atherosclerotic rabbit aortic rings improves relaxations to acetylcholine, Atherosclerosis, 141, 265-271, 1998.
36. Griendling RR, Sorescu D, Ushio-Fukai M, NAD(P)H oxidase role in cardiovascular biology and disease, Circ Res, 86, 494-501, 2000.
37. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK. Superoxide production and expression of Nox family proteins in human atherosclerosis, Circulation, 105, 1429-1435, 2002. (Pubitemid 34263273)
38. Cooke JP. The endothelium: a new target for therapy, Vasc Med, 5, 49-53, 2000.
39. Landmesser U, Dikalov S, Price SR, McCann L, Holland M, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of nitric oxide synthase in hypertension, J Clin Invest, 111, 1201-1209, 2003. (Pubitemid 36519937)
40. Kojda G, Harrison DG. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure, Cardiovasc Res, 43, 562-571, 1999. (Pubitemid 29369255)
41. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein, Free Radic Res Common, 17, 9-20, 1992.
42. d'Uscio LV, Milstien S, Richardson D, Smith L, Katusic ZS. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity, Circ Res, 92, 88-95, 2003.
43. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training, J. Clin Invest, 105, 1631-1639, 2000. (Pubitemid 30390314)
44. Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation, Circulation, 101, 2264-2270, 2000. (Pubitemid 30317128)
45. Ushio-Fukai M, Alexander RW, Akers M, Yin QQ, Fujio Y, Walsh K, Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells, J Biol Chem, 274, 22699-22704, 1999. (Pubitemid 129529292)
46. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox-1, Nature, 401, 79-82, 1999. (Pubitemid 29418446)
47. Mugge A, Brandes RP, Boger RH, Dwenger A, Bode-Boger S, Kienke S, Frolich JC, Lichtlen PR. Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits, J Cardiovasc Pharmacol, 24, 994-998, 1994.
48. Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production, Circulation, 92, 898-903, 1995.
49. Keaney JF Jr. Atherosclerosis, oxidative stress, and endothelial function. In: Keaney JF Jr, (ed), Oxidative Stress and Vascular Disease, Kluwer Academic Publisher, Boston, MA, 155-181, 2000.
50. Mugge A, Elwell JH, Peterson TE, Harrison DG. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity, Am J Physiol, 260, C219-C225, 1991.
51. Kolpakov V, Gordon D, Kulik TJ. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells, Circ Res, 76, 305-309, 1995.
52. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells, Circ Res, 78, 225-230, 1996. (Pubitemid 26042839)
53. Sarkar R, Gordon D, Stanley JC, Webb RC. Dual cell cycle-specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells, J Hypertens, 15, 275-283, 1997. (Pubitemid 27129117)
54. Osinski MT, Rauch BH, Schror K. Antimitogenic actions of organic nitrates re potentiated by sildenafil and mediated via activation of protein kinase A, Mol Pharmacol, 59, 1044-1050, 2001. (Pubitemid 32381583)
55. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldata P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation, Proc Natl Acad Sci USA, 98, 4202-4208, 2001. (Pubitemid 32249922)
56. Yasa M, Kerry Z, Yetik G, Sevin G, Reel B, Ozdemir N, Erhan Y, Ustunes L, Berkan T, Ozer A. Effects of treatment with FK409, a nitric oxide donor, on collar-induced intimal thickening and vascular reactivity, Eur J Pharmacol, 374, 33-39, 1999. (Pubitemid 29296723)
57. Bult H, De Meyer GRY, Herman AG. Influence of chronic treatment with a nitric oxide donor on fatty streak development and reactivity of the rabbit aorta, Br J Pharmacol, 114, 1371-1382, 1995.
58. Provost P, Tremblay J, Merhi Y. The antiadhesive and antithrombotic effects of the nitric oxide donor SIN-1 are combined with a decreased vasoconstriction in a porcine model of balloon angioplasty, Arterioscler Thromb Vasc Biol, 17, 1806-1812, 1997.
59. Guo J, Milhoan KA, Tuam RS, Lefer AM. Beneficial effect of SPM 5185, a cysteine-containing nitric oxide donor, in rat carotid artery intimal injury, Circ Res, 75, 77-84, 1994. (Pubitemid 24187738)
60. Schwarzacher SP, Lim TT, Wang B, Kernoff RS, Niebauer J, Cooke JP, Yeung AC. Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty, Circulation, 95, 1863-1869, 1997.
61. Niebauer J, Schwarzacher SP, Hayase M, Wang B, Kernoff RS, Cooke JP, Yeung AC. Local Larginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis, Circulation, 100, 1830-1835, 1999.
62. Joly GA, Schini VB, Vanhoutte PM. Balloon injury and interleukin-1 beta induce nitric oxide synthase activity in rat carotid arteries, Circ Res, 71, 331-338, 1992.
63. Fukumoto Y, Urabe Y, Kubo T, Kaku T, Egashira K, Shimokawa H, Takeshita A. Augmented vasodilator response to L-arginine after coronary angioplasty may attenuate restenosis, Heart Vessels, 16, 171-174, 2002.
64. Suzuki T, Hayase M, Hibi K, Hosokawa H, Yokoya K, Fitzgerald PS, Yock PG, Cooke JP, Suzuki T, Yeung AC. Effect of local delivery of L-arginine on in-stent restenosis in humans, Am J Cardiol, 89, 363-367, 2002. (Pubitemid 34142506)
65. Libby P. Inflammation in atherosclerosis, Nature, 420, 868-874, 2002.
66. Cybulsky MI, Gimbrone MA. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis, Science, 251, 788-791, 1991.
67. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases, Cardiovasc Pharmacol, 22 (Suppl 4), S1-S14, 1993.
68. Sun Y, Oberley LW. Redox regulation of transcriptional activators, Free Rad Biol Med, 21, 335-348, 1996.
69. Peng H-B, Libby P, Liao JK. Induction and stabilization of IkBa by nitric oxide mediates inhibition of NF-kB, J Biol Chem, 270, 14214-14219, 1995.
70. De Caterina R, Libby P, Peng H-B, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines, J Clin Invest, 96, 60-68, 1995.
71. Gauthier TW, Scalia R, Murohara T, Guo JP, Lefer AM. Nitric oxide protects against leukocyteendothelium interactions in early stages of hypercholesterolemia, Arterioscler Thromb Vasc Biol, 15, 1652-1659, 1995.
72. Lefer DJ, Jones SP, Girod WG, Baines A, Grisham MB, Cockrell AS, Huang PL, Scalia R. Leucocyte-endothelial cell interactions in nitric oxide synthase-deficient mice, Am J Physiol, 276, H1943-H1950, 1999. (Pubitemid 29323478)
73. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure, Proc Natl Acad Sci USA, 86, 3375-3378, 1989. (Pubitemid 19129614)
74. Vallance P, Collier J, Moncada S. Effects of endothelium derived nitric oxide in peripheral arteriolar tone in man, Lancet, 2, 997-1000, 1989. (Pubitemid 19257913)
75. Radomski MW, Palmer RMJ, Moncada S. An Larginine to nitric oxide pathway in human platelets regulates aggregation, Proc Natl Acad Sci USA, 87, 5193-5197, 1990. (Pubitemid 20224299)
76. Dubey RK, Jackson EK, Lüscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat smooth muscle cell. Role of cyclic-nucleotides and angiotensin 1 receptors, J Clin Invest, 96, 141-149, 1995.
77. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension, J Clin Invest, 92, 652-662, 1993. (Pubitemid 23262382)
78. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans, J Clin Invest, 86, 228-234, 1990. (Pubitemid 20226996)
79. Calver A, Collier J, Moncada S, Vallance P. Effect of local intra-arterial Nw-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal, J Hypertens, 10, 1025-1031, 1992.
80. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of Larginine in the hypercholesterolemic rabbit, J Clin Inves, 90, 1168-1172, 1992.
81. Harrison DG. Perspective series: nitric oxide and nitric oxide synthases. Cellular and molecular mechanisms of endothelial cell dysfunction, J Clin Invest, 100, 2153-2157, 1997.
82. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA. Hypertension in micelacking the gene for endothelial nitric oxide synthase, Nature, 377, 239-242, 1995.
83. Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, Huang PL. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice, J Clin Invest, 101, 1225-1232, 1998. (Pubitemid 28145238)
84. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase, J Biol Chem, 270, 319-324, 1995.
85. Ooboshi H, Toyoda K, Faraci FM, Lang MG, Heistad DD. Improvement of relaxation in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase, Arterioscler Thromb Vasc Biol, 18, 1752-1758, 1998. (Pubitemid 28521065)
86. Kullo IJ, Mozes G, Schwartz RS, Gloviczki P, Crotty TB, Barber DA, Katusiz ZS, O'Brien T. Adventitial gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries alters vascular reactivity, Circulation, 96, 2254-2261, 1997. (Pubitemid 27425831)
87. Kullo IJ, Simari RD, Schwartz RS. Vascular gene transfer: from bench to bedside, Arterioscler Thromb Vasc Biol, 19, 196-207, 1999.
88. Smith SC Jr, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K, Fuster V, Gotto A, Grundy SM, Miller NH, Jacobs A, Jones D, Krauss RM, Mosca L, Ockere I, Pasternak RC, Pearson T, Pfeffer MA, Starke RD, Taubert KA. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology, J Am Coll Cardiol, 38, 1581-1583, 2001.
89. Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, Baither Y, Gielen S, Thiele H, Gummert JF, Mohr FW, Schuler G. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phospholylation of endothelial nitric oxide synthase, Circulation, 107, 3152-3158, 2003.
90. Vogel RA, Corretti MC, Plotnick GD. The postprandial effect of components of the Mediterranean diet on endothelial function, J Am Coll Cardiol, 36, 1455-1460, 2000.
91. Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff PL, Frei B, Vita JA. Short- and longterm black tea consumption reverses endothelial dysfunction in patients with coronary artery disease, Circulation, 104, 151-156, 2001. (Pubitemid 32655830)
92. Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Foltas JD. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease, Circulation, 100, 1050-1055, 1999.
93. Agewall S, Wright S, Doughty RN, Whalley GA, Duxbury M, Sharpe N. Does a glass of red wine improve endothelial function?, Eur Heart J, 21, 74-78, 2000.
94. Goode GK, Garcia S, Heagerty AM. Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients, Circulation, 96, 2802-2807, 1997.
95. Lissin L, Cooke JP. Phytoestrogens and their effects on the cardiovascular system, J Am Coll Cardiol, 35, 1403-1410, 2000.
96. Creager MA, Gallagher SJ, Girerd XJ, Coleman S, Dzau VJ, Cooke J.P. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans, J Clin Invest, 90, 1248-1253, 1992.
97. Frei B. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction, Proc Soc Exp Biol Med, 222, 196-204, 1999.
98. Boger RH, Bode-Boger SM, Phivthong-ngam L, Brandes RP, Schwedhelm E, Mugge A, Bohme M, Tsikas D, Frolich JC. Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms, Atherosclerosis, 141, 31-43, 1998.
99. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients non-insulindependent diabetes mellitus, J Clin Invest, 97, 22-28, 1996.
100. Anderson TJ, Meredith IT, Young AC, Frei B,Schwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion, N Engl J Med, 332, 488-493, 1995.
101. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF Jr, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease, Circulation, 93, 1107-1113, 1996.
102. Mancini GBJ, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study, Circulation, 94, 258-265, 1996.
103. Drexler H, Kurz S, Jeserich M, Münzel T, Hornig B. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure, Am J Cardiol, 76, 13E-18E, 1995.
104. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease, N Engl J Med, 332, 481-487, 1995.
105. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone, J Clin Invest, 97, 1916-1923, 1996.
106. Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors, Circulation, 97, 1129-1135, 1998.
107. Lefer AM, Scalia R, Lefer DJ. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease, Cardiovasc Res, 49, 281-287, 2001.
108. Varenne O, Pislaru S, Gillijns H, Van Pelt N, Gerard RD, Zoldhelyi P, Van de Werf F, CollenD, Janssens SP. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs, Circulation, 98, 919-926, 1998.
109. Sinnaeve P, Chiche JD, Nong Z, Varenne O, Van Pelt N, Gillijns H, Collen D, Bloch KD, Janssens S. Soluble guanylate cyclase a1 and b1 gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects, Circ Res, 88, 103-109, 2001.